Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Nov;74(11):4927–4931. doi: 10.1073/pnas.74.11.4927

Binding of the endogenous nonpeptide morphine-like compound to opiate receptors.

A J Blume, J Shorr, J P Finberg, S Spector
PMCID: PMC432070  PMID: 200939

Abstract

The endogenous central nervous tissue substance called MLC (morphine-like compound) is shown to bind to the opiate receptors of the mouse neuroblastoma X glioma hybrid cell line NG108-15. The interaction of MLC with these opiate receptors is noncooperative, as is the interaction of morphine, naloxone, and Leu-enkephalin with these receptors. A specific antibody to morphine will bind MLC but will not bind beta-endorphin, Leu-enkephalin, or Met-enkephalin. It would appear, therefore, that MLC can be considered to be a different type of endogenous ligand for the opiate receptor.

Full text

PDF
4927

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox B. M., Goldstein A., Hi C. H. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proc Natl Acad Sci U S A. 1976 Jun;73(6):1821–1823. doi: 10.1073/pnas.73.6.1821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cox B. M., Opheim K. E., Teschemacher H., Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci. 1975 Jun 15;16(12):1777–1782. doi: 10.1016/0024-3205(75)90272-6. [DOI] [PubMed] [Google Scholar]
  3. Gintzler A. R., Levy A., Spector S. Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2132–2136. doi: 10.1073/pnas.73.6.2132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldstein A., Cox B. M., Klee W. A., Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 1977 Jan 27;265(5592):362–363. doi: 10.1038/265362a0. [DOI] [PubMed] [Google Scholar]
  5. Guillemin R., Ling N., Burgus R. Endorphines, peptides, d'origine hypothalamique et neurohypophysaire à activité morphinomimétique. Isolement et structure moléculaire de l'alpha-endorphine. C R Acad Sci Hebd Seances Acad Sci D. 1976 Feb 23;282(8):783–785. [PubMed] [Google Scholar]
  6. Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 1975 May 2;88(2):295–308. doi: 10.1016/0006-8993(75)90391-1. [DOI] [PubMed] [Google Scholar]
  7. Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975 Dec 18;258(5536):577–580. doi: 10.1038/258577a0. [DOI] [PubMed] [Google Scholar]
  8. KUPFERBERG H., BURKHALTER A., WAY E. L. A SENSITIVE FLUOROMETRIC ASSAY FOR MORPHINE IN PLASMA AND BRAIN. J Pharmacol Exp Ther. 1964 Aug;145:247–251. [PubMed] [Google Scholar]
  9. Klee W. A., Nirenberg M. A neuroblastoma times glioma hybrid cell line with morphine receptors. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3474–3477. doi: 10.1073/pnas.71.9.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klee W. A., Nirenberg M. Mode of action of endogenous opiate peptides. Nature. 1976 Oct 14;263(5578):609–612. doi: 10.1038/263609a0. [DOI] [PubMed] [Google Scholar]
  11. Pasternak G. W., Goodman R., Snyder S. H. An endogenous morphine-like factor in mammalian brain. Life Sci. 1975 Jun 15;16(12):1765–1769. doi: 10.1016/0024-3205(75)90270-2. [DOI] [PubMed] [Google Scholar]
  12. Sharma S. K., Klee W. A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A. 1975 Aug;72(8):3092–3096. doi: 10.1073/pnas.72.8.3092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sharma S. K., Nirenberg M., Klee W. A. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci U S A. 1975 Feb;72(2):590–594. doi: 10.1073/pnas.72.2.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Spector S., Parker C. W. Morphine: radioimmunoassay. Science. 1970 Jun 12;168(3937):1347–1348. doi: 10.1126/science.168.3937.1347. [DOI] [PubMed] [Google Scholar]
  15. TPERENIUS L., Wahlström A. Morphine-like ligand for opiate receptors in human CSF. Life Sci. 1975 Jun 15;16(12):1759–1764. doi: 10.1016/0024-3205(75)90269-6. [DOI] [PubMed] [Google Scholar]
  16. Waterfield A. A., Smokcum R. W., Hughes J., Kosterlitz H. W., Henderson G. In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol. 1977 May 15;43(2):107–116. doi: 10.1016/0014-2999(77)90123-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES